Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from MyCelx Technologies ( (GB:MYX) ).
MyCelx Technologies Corporation reported a decrease in revenue for the first half of 2025 due to the sale of its Saudi Arabia branch assets in 2024. Despite this, the company achieved a higher gross margin from recurring media sales and trials. Operationally, MyCelx secured a significant contract with the U.S. Department of Defense for PFAS treatment and completed a successful trial in the Permian Basin, positioning its technology as a cost-effective solution for water treatment. Looking forward, MyCelx anticipates substantial revenue growth in the second half of 2025, driven by major projects in Nigeria and the Middle East, as well as increased demand for its PFAS and produced water treatment technologies.
More about MyCelx Technologies
MyCelx Technologies Corporation operates in the clean water and clean air technology industry, focusing on transforming the environmental impact of industrial processes. The company specializes in solutions for PFAS remediation and produced water treatment, with a market focus on large-scale industrial applications, including oil producers and defense installations.
Average Trading Volume: 35,358
Technical Sentiment Signal: Sell
Current Market Cap: £6.33M
Learn more about MYX stock on TipRanks’ Stock Analysis page.